ARCHIVES

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

This article is from The Cancer Letter archive.

Vol. 34 No. 01 | January 11, 2008

Download PDF Visit The Full Archive

Related Articles

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977

NIH Funding Opportunities Listed

March 13, 2009

QOL Of Anemic Patients Improved With Darbepoetin

June 28, 2002

Concept Approved For New Quality Assurance Center

May 14, 1982